Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics

CE Demeure, O Dussurget, G Mas Fiol… - Genes & …, 2019 - nature.com
Plague is a vector-borne disease caused by Yersinia pestis. Transmitted by fleas from
rodent reservoirs, Y. pestis emerged< 6000 years ago from an enteric bacterial ancestor …

Advances in aquaculture vaccines against fish pathogens: global status and current trends

M Dadar, K Dhama, VN Vakharia… - Reviews in Fisheries …, 2017 - Taylor & Francis
In recent years, aquaculture has attained a major economic revolution, however, infectious
diseases of bacterial, viral, mycotic and parasitic origin are the most significant restrictive …

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

DG Heath, GW Anderson Jr, JM Mauro, SL Welkos… - Vaccine, 1998 - Elsevier
The current human whole-cell vaccine is ineffective against pneumonic plague caused by
typical F1 capsule positive (F1+) strains of Yersinia pestis. The authors found this vaccine to …

The type III secretion system tip complex and translocon

CA Mueller, P Broz, GR Cornelis - Molecular microbiology, 2008 - Wiley Online Library
The type III secretion machinery of Gram‐negative bacteria, also known as the injectisome
or needle complex, is composed of a basal body spanning both bacterial membranes and …

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and-negative strains of Yersinia pestis

GW Anderson Jr, SE Leary, ED Williamson… - Infection and …, 1996 - Am Soc Microbiol
The purified recombinant V antigen from Yersinia pestis, expressed in Escherichia coli and
adsorbed to aluminum hydroxide, an adjuvant approved for human use, was used to …

Vaccination against bubonic and pneumonic plague

RW Titball, ED Williamson - Vaccine, 2001 - Elsevier
Yersinia pestis is the etiological agent of bubonic and pneumonic plague, diseases which
have caused over 200 milllion human deaths in the past. Plague still occurs throughout the …

Human immune response to a plague vaccine comprising recombinant F1 and V antigens

ED Williamson, HC Flick-Smith, C Lebutt… - Infection and …, 2005 - Am Soc Microbiol
The human immune response to a new recombinant plague vaccine, comprising
recombinant F1 (rF1) and rV antigens, has been assessed during a phase 1 safety and …

Current challenges in the development of vaccines for pneumonic plague

ST Smiley - Expert review of vaccines, 2008 - Taylor & Francis
Inhalation of Yersinia pestis bacilli causes pneumonic plague, a rapidly progressing and
exceptionally virulent disease. Extensively antibiotic-resistant Y. pestis strains exist and we …

A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague

P Tao, M Mahalingam, J Zhu, M Moayeri, J Sha… - MBio, 2018 - Am Soc Microbiol
Bacillus anthracis and Yersinia pestis, the causative agents of anthrax and plague,
respectively, are two of the deadliest pathogenic bacteria that have been used as biological …

Cell-Mediated Protection against Pulmonary Yersinia pestis Infection

MA Parent, KN Berggren, LW Kummer… - Infection and …, 2005 - Am Soc Microbiol
Pulmonary infection with the bacterium Yersinia pestis causes pneumonic plague, an often-
fatal disease for which no vaccine is presently available. Antibody-mediated humoral …